To assess predictors of PSMA expression in a genomic database; positron emission tomography (PET) with PSMA-targeted radiopharmaceuticals is increasingly being utilized.
The de-identified Decipher Biosciences database (GRID), which includes expression for more than 46,000 coding and noncoding genes per patient, was queried for expression of FOLH1 (PSMA).